Effect of the "Sitting Out of Bed in an Arm-chair Position" in ICU on Functional Recovery Among Ventilated Patients
STORM
1 other identifier
interventional
150
1 country
11
Brief Summary
Chair positioning is one of a series of early mobilization techniques. At present, this technique, which involves moving a patient out of the resuscitation bed, can be performed passively or actively. It does not constitute a rehabilitative act as such, but it is considered in common paradigms as a technique to improve "the patient's breathing and strength". However, recommendations issued in 2013 by the Society of intensive care physiotherapy and the society "Société de réanimation de langue française (SRLF)", reveal that this chair position cannot be recommended with a high grade. The aim of the investigators is therefore to break down this early mobilization process in intensive care, to find out whether the armchair is an indispensable tool for improving functional and muscular processes. The research hypothesis is therefore as follows: "Early armchairing of the resuscitation patient, improves functional recovery compared to a conservative positioning strategy (sitting in bed)."
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2025
Typical duration for not_applicable
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2025
CompletedFirst Posted
Study publicly available on registry
May 15, 2025
CompletedStudy Start
First participant enrolled
July 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
December 19, 2025
December 1, 2025
2.5 years
April 28, 2025
December 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional level on "discharge" from intensive care
Functional level at "discharge" from the intensive care unit measured by the Physical Function ICU Test scored (PFIT-s). Minimum value = 0 , meaning worse functionnal status Maximum value = 12, meaning better functionnal status
On discharge from intensive care or day 28 (depending on which comes first)
Secondary Outcomes (7)
ICU Mobility scale
Day 28
MRC sum score
Day 28
Length of stay in intensive care unit
Day 28
Ventilator free days
Day 28
Mortality rate
Day 28
- +2 more secondary outcomes
Study Arms (2)
sitting out of bed in an arm-chair position
EXPERIMENTALNo chair position
NO INTERVENTIONInterventions
Once the patient has been awake with a RASS score between -1 and +1 for more than 12 hours, he or she must be placed in a chair (by any means) every day for a minimum of 30 minutes until "discharge" from intensive care (or until D28, depending on which comes first), unless there are transient contraindications. If the patient is unable to signal his or her wish to stop the chair session, the criteria for intolerance will be sought and the patient placed in the chair, but in all cases the chair session will not exceed 4 hours.
Eligibility Criteria
You may qualify if:
- Patient \> 18 years old
- Patient on invasive mechanical ventilation for more than 24 hours
- Patient in recovery phase with a RASS score greater than "-3" for more than 12 hours
- Stay expected to last 48 hours
- Patient has never been placed in a chair during this hospitalization in intensive care.
- Fragility score \< 6, during the month preceding admission to intensive care
- Patient (or support person/relative if patient is unable to participate) who has agreed to take part in the study.
You may not qualify if:
- Patient with an absolute and non-resolving contraindication to chair positioning
- Fracture or orthopedic disorder contraindicating mobilization out of bed
- Obesity with body mass index greater than 45 kg/cm2
- Sacral eschar stage greater than 2
- Patient using a wheelchair for mobility (i.e. paraplegic patient or patient with progressive neurological pathology).
- Patient treated with veno-venous or veno-arterial ECMO at the time of screening.
- Moribund patient
- Encephalic death
- Acute polyradiculoneuritis (Guillain-Barré syndrome)
- Myasthenia
- Patient treated by continuous hemodialysis or hemofiltration for more than 72 hours following the onset of awakening.
- Complete transmetatarsal or higher amputation of one or both lower limbs.
- Protected person (under guardianship or curatorship)
- Person under court protection
- Person not affiliated to a social security scheme
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (11)
Centre Hospitalier Universitaire d'Orléans
Orléans, Centre-Val de Loire, 45067, France
Hopital Nord Franche Comte
Belfort, France
CHU Clermont Ferrand
Clermont-Ferrand, France
CH de DAX
Dax, 40100, France
CHU de DIJON
Dijon, France
CH Chartres
Le Coudray, 28630, France
Ch Du Mans
Le Mans, 72037, France
CHI Mont de Marsan
Mont-de-Marsan, 40012, France
CH de Saint-Lô
Saint-Lô, France
Hopital Foch
Suresnes, France
CHRU de TOURS
Tours, France
Study Officials
- PRINCIPAL INVESTIGATOR
Guillaume FOSSAT
CHU Orléans
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2025
First Posted
May 15, 2025
Study Start
July 4, 2025
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
January 1, 2028
Last Updated
December 19, 2025
Record last verified: 2025-12